You need to enable JavaScript to run this app.
Recon: Roche to buy obesity drugmaker Carmot Therapeutics for $2.7B; Supreme Court hears oral arguments in Purdue bankruptcy case
Recon
Jason Scott
Global
ReconJason Scott
GlobalReconJason ScottGlobal